A method was developed for the preparation of genomic DNA from clotted blood that is usually discarded after extraction, for other laboratory tests. The method, which involves proteinase K digestion, salt/chloroform extraction and 90% ethanol precipitation of DNA from clotted blood, is rapid, sinple, and easy because it does not inpose an extra burden on the patient. ( Clin Pathol 1994;47:1043- usually exceeds that required, and an anticoagulant (such as EDTA) must be added. Direct polymerase chain reaction (PCR) amplification from blood has also been devised,23 but the sample cannot be stored as DNA for further investigation. On the other hand, clotted blood left after collection of serum for other laboratory tests is usually discarded. We therefore developed a method of using this clotted blood for genetic analysis. This method frees the patient from any inconvenience involved in the taking of surplus blood, and is especially useful for children.
Genetic tests or screening for diseases or disease susceptibility are based on blood as a source of genomic DNA. Genomic DNA is usually prepared from white cells or whole blood.' However, isolation of white cells requires density gradient centrifugation (using a medium such as Ficoll-Hypaque), and this is very time consuming when many samples have to be prepared. Even when whole blood is used, the amount collected 1 2 3 4 5 6 7 8 9 10 11 DNA incubated at 37°C and amplified PCR products electrophoresed on 2% agarose. usually exceeds that required, and an anticoagulant (such as EDTA) must be added. Direct polymerase chain reaction (PCR) amplification from blood has also been devised,23 but the sample cannot be stored as DNA for further investigation. On the other hand, clotted blood left after collection of serum for other laboratory tests is usually discarded. We therefore developed a method of using this clotted blood for genetic analysis. This method frees the patient from any inconvenience involved in the taking of surplus blood, and is especially useful for children.
Method
Throughout the process, 1-5 ml tubes are used so that many samples can be prepared easily and at the same time. Lysis solution (360 ug/ml proteinase K, 150 mM sodium chloride, 50 mM EDTA, 2% sodium dodecyl sulphate, divided into 250,u aliquots in 1-5 ml tubes and stored at -20°C) can be prepared beforehand. Two hundred microlitres of fresh blood clot or a freeze-thawed clot is aspirated with a 2 ml disposable serum pipette using rather strong negative pressure, mixed with lysis solution, and incubated at 55-65°C for three hours with periodic mixing, avoiding aggregation of the clot at the bottom of the tube. After incubation, 150 ul of saturated NaCl (nearly 6 M) and 6001,ul of chloroform are added and mixed vigorously for 10 minutes by inverting the tube. Phase separation is achieved by centrifugation at 5000 rpm for five minutes. The upper 400 gl of the aqueous phase is transferred to a fresh 1-5 ml tube containing 800 pl of 90% ethanol. The pellet is recovered by centrifugation of 5000 rpm for five minutes. After washing with 70% ethanol, the pellet is resuspended in 100 ,ul of TE (10 mM TRIS-HCG, 1 mM EDTA) buffer.
Results
We modified the salt/chloroform extraction method for nucleated cells3 and found it suitable for extracting DNA from clotted blood. The extracted DNA is colourless, not sheared, and free of protein, pigment, salt and RNA. The amount of DNA comprises about 10 ,ug, enough for more than 100 PCRs. No degradation was found after incubation at 37°C for one month (figure), indicating the long term stability of the sample at 4°C. The clotted blood before DNA extraction can be stored at -20°C in the tube used for serum separation for up to a month, and can be transferred on dry ice to other laboratories.
Discussion
The salt/chloroform method is better than the use of phenol, because it avoids having to use a dangerous solvent. However, unlike the procedure described before,4 neither absolute ethanol nor propanol are recommended for DNA precipitation because it also precipitates salts and blood pigments, which inhibit polymerases and restriction enzymes. This method is simple, rapid, economical, and within the scope of most clinical laboratories. It facilitates the collection of many samples for studies of genetic disorders because it uses normally discarded blood clots, and is widely applicable to medical, genetic, epidemiological, and forensic studies. 
